Facebook
Britain's News Portal
Around The Clock
BREAKING
Loading latest headlines…

Concerns Raised Over 'Menopause Gold Rush' and 'Pink Tax' on Wellness Products

The global perimenopause market is projected to reach $25bn by 2030, but concerns are growing about the exploitation of women through 'menowashing' and a 'pink tax' on products.

  • The global perimenopause market is projected to be worth up to $25bn by 2030.
  • A paper co-authored by Professor Joyce Harper found wide variations in ingredients and price of over 200 menopause supplements, with limited empirical evidence of efficacy.
  • The consumer magazine Which? has warned of a 'pink tax' where standard products are sold at a higher price when rebranded for menopause.

The perimenopause market is expected to reach $25bn by 2030, driven by pharmaceutical companies addressing women's health needs. However, the consumer side of this market is experiencing rapid growth, with brands offering a wide array of menopause-friendly products.

Concerns have been raised about a 'menopause gold rush', where women may be exploited through products with limited scientific backing. Professor Joyce Harper of UCL co-authored a paper reviewing over 200 menopause supplements, noting significant variations in ingredients and price, and a lack of consensus on their effectiveness. Only vitamin D and calcium are recommended by medical experts for bone health, with sufficient proof of efficacy.

The consumer magazine Which? has also highlighted a 'pink tax', where manufacturers may sell standard products like moisturiser and vitamins at a higher price simply by rebranding them for menopause. This trend has led to questions about 'menowashing', where brands use women's health needs to sell potentially unnecessary items during a vulnerable time.

An event in London, Pause Live, showcased a range of products from menthol lotions to herbal supplements and 'pant magnets' for hot flushes. While some attendees viewed it as a social outing, others expressed disappointment over the lack of focus on mental health and concerns about 'menowashing'.

Why this matters: This trend highlights the growing commercialisation of menopause, raising questions about product efficacy, pricing practices, and the potential vulnerability of consumers.

What this means for you: You may encounter products marketed specifically for menopause that are standard items sold at a higher price, or supplements with limited scientific evidence of efficacy.

Related Articles

Get the news that matters.

Join thousands of readers getting the best of British news straight to their inbox.